Chairman Waxman Writes President Obama Regarding Generic Biologics

Jun 8, 2009

In a letter to President Obama, Chairman Waxman praised the President for his support of generic biologics in the FY 2010 Budget, with a term of exclusivity consistent with that granted to other drugs under Waxman-Hatch. Chairman Waxman urged the President to consider what steps can be taken under current law to prepare and even begin to approve safe and effective generic biologics, in advance of legislation. In March, Chairman Waxman introduced H.R. 1427 the "Promoting Innovation and Access to Life-Saving Medicine Act," a bipartisan bill to allow the FDA to approve affordable generic biologic drugs.

Recent News


Leading Energy and Commerce Democrats Clarify Congressional Intent of Spectrum Provisions, Urge Serious Consideration of DOJ Views 05/16/2013
Rep. Waxman Releases Report on State by State Impact of Repealing the Affordable Care Act 05/15/2013
Rep. Waxman Lauds Covered California Awards to Community Organization for Affordable Care Act Outreach and Education 05/14/2013
Committee Democrats Release Memorandum Criticizing Republican Staff Report on Impact of the Affordable Care Act 05/13/2013
Committee Releases White Paper Examining Environmental Impacts of Renewable Fuel Standard 05/09/2013
Rep. Waxman and Sen. Whitehouse Urge EPA to Reconsider Decision Not to Regulate Methane Emissions from Coal Mines 05/07/2013
Ranking Members Waxman and Thompson Urge President to Establish Blue Ribbon Commission on Chemical Facility Security 05/02/2013
Rep. Waxman Statement on President Obama’s Nomination for FCC Chairman 05/01/2013
California Democrats Request Grid Operator Plan to Maintain Reliability 04/26/2013
Committee Continues Bipartisan Review of Renewable Fuel Standard with Examination of Agricultural Impacts 04/18/2013